Clear Trail Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.18M Sell
48,476
-645
-1% -$56.8K 0.64% 46
2026
Q2
$3.84M Sell
49,121
-15,585
-24% -$1.26M 0.59% 48
2026
Q1
$5.61M Buy
64,706
+20,094
+45% +$1.92M 0.93% 32
2025
Q4
$4.29M Buy
+44,612
New +$4.33M 0.99% 29

Other funds holding MDT

Clear Trail Advisors's MDT Position: Q3 2026 in Review

Clear Trail Advisors reduced its Medtronic (MDT) stake by 1.3% in Q3 2026, selling an estimated $56.8K and leaving 48,476 shares worth $4.18M. The position accounts for 0.64% of the portfolio, ranked #46.

Clear Trail Advisors first reported a position in MDT in Q4 2025 and has held it in 4 quarters since. The position peaked at $5.61M in Q1 2026. 2,200 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Clear Trail Advisors held 48,476 shares of Medtronic worth $4.18M as of Q3 2026.
  • Clear Trail Advisors sold 645 Medtronic shares in Q3 2026, an estimated $56.8K.
  • Medtronic made up 0.64% of Clear Trail Advisors's portfolio in Q3 2026, its #46 holding.
  • Clear Trail Advisors first reported a position in Medtronic in Q4 2025 and has held it in 4 quarters since.
  • Clear Trail Advisors's Medtronic position peaked at $5.61M in Q1 2026.
  • 2,200 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Clear Trail Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.